剰余金の配当(中間配当)、有価証券及び投資有価証券の取得による支出、売上収益(IFRS)他2件
- 【期間】
年度 | 剰余金の配当(中間配当) | 有価証券及び投資有価証券の取得による支出 | 売上収益(IFRS) | 全事業営業利益又は全事業営業損失(△) - 医薬・バイオケミカル | 繰延税金資産(IFRS) |
---|
2008/12 | - | | -21.4億 | | - | | - | | - | |
2009/12 | - | | -1373億 | 赤拡 | - | | - | | - | |
2010/03 | - | | -3.08億 | 赤縮 | - | | - | | - | |
2010/06 | - | | -3.83億 | 赤拡 | - | | - | | - | |
2010/09 | - | | -865億 | 赤拡 | - | | - | | - | |
2010/12 | - | | -870億 | 赤拡 | - | | - | | - | |
2011/03 | - | | -81.9億 | 赤縮 | - | | - | | - | |
2011/06 | - | | -43.4億 | 赤縮 | - | | - | | - | |
2011/09 | - | | -2464億 | 赤拡 | - | | - | | - | |
2011/12 | -130億 | | -443億 | 赤縮 | - | | - | | - | |
2012/06 | - | | -46.1億 | 赤縮 | - | | - | | - | |
2012/12 | -130億 | 赤縮 | -96.4億 | 赤拡 | - | | 555億 | | - | |
2013/03 | - | | - | | - | | - | | - | |
2013/06 | - | | -24.6億 | 赤縮 | - | | - | | - | |
2013/09 | - | | - | | - | | - | | - | |
2013/12 | - | | -44.2億 | 赤拡 | - | | 543億 | -2.1% | - | |
2014/03 | - | | - | | - | | - | | - | |
2014/06 | - | | -81.5億 | 赤拡 | - | | - | | - | |
2014/09 | - | | - | | - | | - | | - | |
2014/12 | - | | -267億 | 赤拡 | - | | 389億 | -28.5% | - | |
2015/03 | - | | - | | - | | - | | - | |
2015/06 | - | | -57.4億 | 赤縮 | - | | - | | - | |
2015/09 | - | | - | | - | | - | | - | |
2015/12 | - | | -107億 | 赤拡 | - | | 468億 | +20.4% | - | |
2016/03 | - | | - | | - | | - | | - | |
2016/06 | - | | -55.4億 | 赤縮 | - | | - | | - | |
2016/09 | - | | - | | - | | - | | - | |
2016/12 | - | | -208億 | 赤拡 | - | | 347億 | -25.8% | - | |
2017/03 | - | | - | | - | | - | | - | |
2017/06 | - | | -109億 | 赤縮 | - | | - | | - | |
2017/09 | - | | - | | - | | - | | - | |
2018/12 | - | | - | | 1.93兆 | | - | | 887億 | |
2019/03 | - | | - | | 0.43兆 | -77.5% | - | | - | |
2019/06 | - | | - | | 0.93兆 | +114.1% | - | | - | |
2019/09 | - | | - | | 1.44兆 | +54.6% | - | | - | |
2019/12 | - | | - | | 1.94兆 | +35% | - | | 947億 | +6.7% |
2020/03 | - | | - | | 0.42兆 | -78.1% | - | | 942億 | -0.4% |
2020/06 | - | | - | | 0.87兆 | +105.5% | - | | 972億 | +3.2% |
2020/09 | - | | - | | 1.36兆 | +55.8% | - | | 1010億 | +3.9% |
2020/12 | - | | - | | 1.85兆 | +36% | - | | 1015億 | +0.5% |
2021/03 | - | | - | | 0.41兆 | -77.9% | - | | 1026億 | +1.1% |
2021/06 | - | | - | | 0.86兆 | +111.1% | - | | 1053億 | +2.6% |
2021/09 | - | | - | | 1.33兆 | +53.5% | - | | 1030億 | -2.2% |
2021/12 | - | | - | | 1.82兆 | +37.3% | - | | 1094億 | +6.2% |
2022/03 | - | | - | | 0.42兆 | -77.1% | - | | 1136億 | +3.9% |
2022/06 | - | | - | | 0.92兆 | +120.1% | - | | 1212億 | +6.7% |
2022/09 | - | | - | | 1.46兆 | +58.9% | - | | 1319億 | +8.9% |
2022/12 | - | | - | | 1.99兆 | +36.5% | - | | 1113億 | -15.6% |
2023/03 | - | | - | | 0.45兆 | -77.4% | - | | 1128億 | +1.3% |
2023/06 | - | | - | | 0.97兆 | +115.4% | - | | 1173億 | +4% |
2023/09 | - | | - | | 1.55兆 | +59.5% | - | | 1153億 | -1.7% |
2023/12 | - | | - | | 2.13兆 | +37.9% | - | | 1093億 | -5.2% |
2024/03 | - | | - | | 0.5兆 | -76.5% | - | | 1030億 | -5.8% |